Sanborn Kilcollin Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | $8.68M | Sell |
309,551
-161,267
| -34% | -$4.52M | 6.07% | 8 |
|
|
2014
Q2 | $13.3M | Buy |
470,818
+3,797
| +0.8% | +$107K | 6.11% | 6 |
|
|
2014
Q1 | $14.2M | Buy |
467,021
+22,454
| +5% | +$684K | 7.18% | 6 |
|
|
2013
Q4 | $12.9M | Sell |
444,567
-27,865
| -6% | -$810K | 6.73% | 6 |
|
|
2013
Q3 | $12.9M | Buy |
472,432
+38,139
| +9% | +$1.04M | 6.79% | 6 |
|
|
2013
Q2 | $11.5M | Buy |
+434,293
| New | +$11.5M | 7.02% | 4 |
|